Ropes & Gray advised EQRx on the deal.EQRx closed a strategic drug creation, development, and commercialization collaboration with Exscientia. The collaboration combines Exscientia’s leading AI-driven drug discovery…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
